Bowling Portfolio Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,577
Closed -$1.52M 322
2019
Q3
$1.52M Sell
11,577
-317
-3% -$41.3K 0.25% 126
2019
Q2
$1.44M Sell
11,894
-1,900
-14% -$225K 0.24% 157
2019
Q1
$1.7M Sell
13,794
-35
-0.3% -$4.39K 0.27% 119
2018
Q4
$1.62M Buy
13,829
+5,739
+71% +$676K 0.29% 110
2018
Q3
$1.01M Buy
+8,090
New +$893K 0.14% 240
2018
Q2
Sell
-35,150
Closed -$2.12M 323
2018
Q1
$2.12M Sell
35,150
-5,561
-14% -$317K 0.29% 120
2017
Q4
$2.15M Buy
+40,711
New +$2.15M 0.29% 113

Other funds holding AMED

Bowling Portfolio Management's AMED Position: Q4 2019 in Review

Bowling Portfolio Management sold out of Amedisys (AMED) in Q4 2019, closing a stake of 11,577 shares — an estimated $1.52M sold.

Bowling Portfolio Management first reported a position in AMED in Q4 2017 and held it in 7 quarters. The position peaked at $2.15M in Q4 2017. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2019.

  • Bowling Portfolio Management reported no remaining Amedisys position as of Q4 2019 after selling out during the quarter.
  • Bowling Portfolio Management sold 11,577 Amedisys shares in Q4 2019, an estimated $1.52M.
  • Bowling Portfolio Management first reported a position in Amedisys in Q4 2017 and held it in 7 quarters.
  • Bowling Portfolio Management's Amedisys position peaked at $2.15M in Q4 2017.
  • 325 funds tracked by Wall St. Rank held Amedisys as of Q4 2019.

Based on Bowling Portfolio Management's 13F filing for Q4 2019, filed 17 Jan 2020.